Case Report
Copyright ©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101664
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101664
Figure 3
Figure 3 Temporal response of eosinophil count following triclabendazole treatment in a patient with hepatic eosinophilic pleural effusion secondary to Fasciola hepatica infection. The dynamic changes in eosinophil levels are shown. A marked reduction of eosinophil levels occurred after a single dose of triclabendazole, highlighting the efficacy of triclabendazole in the therapeutic management of parasitic hepatic eosinophilic pseudotumor.